Clinical Trials Logo

Filter by:
NCT ID: NCT06261580 Completed - Healthy Clinical Trials

Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers

Start date: July 28, 2021
Phase:
Study type: Observational

This trial holds minimal risk to the trial volunteers and consists of obtaining whole blood via venipuncture to perform coagulation parameter measurements to define a Normal Reference Range. Written consent to participate in the study will be obtained prior to volunteer screening per site procedures.

NCT ID: NCT06261528 Recruiting - Clinical trials for Progressive Multiple Sclerosis

Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis

NO-FATIGUE
Start date: April 18, 2024
Phase: Phase 1
Study type: Interventional

The study is being done to determine if treatment with a novel form of light therapy is tolerated in patients with progressive multiple sclerosis. The goal of this trial to establish the safety profile of this light therapy while generating data on its impact on fatigue, as well as its mechanism of action. Fatigue is often a complex symptom in multiple sclerosis, without any FDA-approved direct therapy. Fatigue is traditionally treated with symptom management through a multidisciplinary team.

NCT ID: NCT06261476 Recruiting - Healthy Clinical Trials

Safety of Ashwagandha (Withania Somnifera) Root Extract

Start date: February 2024
Phase: N/A
Study type: Interventional

The primary objective is to evaluate the laboratory safety of Ashwagandha standardized root extract 500 mg capsules in healthy adults over 12-week therapy based on Complete Blood Count, Renal Function Test, Liver Function Test, Lipid Profile and Thyroid Function Test, Fasting blood sugar and HbA1c Test. The secondary objectives are to evaluate the clinical safety of Ashwagandha standardized root extract 500 mg capsules in healthy adults over 12-week therapy and to evaluate the effect of the Ashwagandha standardized root extract 500 mg on Quality of Life (QoL) using the SF-36 tool.

NCT ID: NCT06261463 Recruiting - Depression Clinical Trials

Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families

Start date: May 31, 2024
Phase: N/A
Study type: Interventional

The proposed study draws on prior research to evaluate the feasibility, acceptability and explore preliminary effectiveness of Coffee and Family Education and Support, Version (CAFES2) using a pilot randomized type 1 hybrid effectiveness-implementation design. CAFES2 is a peer-led family and social strengthening multiple family group intervention that is designed to respond to multi-level needs of refugee families. Results of the trial will contribute to the emerging evidence base on family-based mental health interventions for refugee and newcomer communities. The trial will also generate new insights regarding implementation strategies needed to promote successful delivery of services by peer providers and the unique role of human-centered design practices for adaptation of mental health and psychosocial interventions.

NCT ID: NCT06261437 Not yet recruiting - Healthy Volunteers Clinical Trials

Effect of Ration Formulations on Warfighter Energy Balance and Physical Performance During a Field Training Exercise

Start date: February 22, 2024
Phase: N/A
Study type: Interventional

The goal of this randomized clinical trial is to determine the effects of consuming the Close Combat Assault Ration (CCAR) compared to the First Strike Ration (FSR) during a 7-day strenuous military training on energy intake and energy balance in healthy, Active Duty Warfighters. The main questions it aims to answer are: - Will consuming the CCAR result in lower energy intake or energy balance compared to consumption of the FSR? - Will consuming the CCAR result in lower lower body strength or anaerobic power compared to consuming the FSR? - Will those consuming the CCAR report lower ration acceptability or greater gastrointestinal side effects compared to those consuming the FSR? Participants will be asked to consume either the CCAR or FSR as the sole nutrition source during a 7-day field training exercise (FTX). The vertical jump test, running-based anaerobic sprint test, and lower-body strength pull will be conducted pre and post the 7-day FTX to assess physical performance. Energy expenditure and intake will be measured by the doubly-labelled water method and dietary logs, respectively. Surveys will be completed to assess ration acceptability and gastrointestinal symptoms. Researchers will compare the CCAR and FSR groups to see if their consumption impacted energy intake, energy balance, physical performance, ration acceptance, or gastrointestinal side effects.

NCT ID: NCT06261398 Recruiting - Pregnancy Clinical Trials

Better Birth Outcomes Through Technology, Education, and Reporting

BETTER
Start date: February 26, 2024
Phase: N/A
Study type: Interventional

This is a pragmatic randomized control trial to evaluate the BETTER intervention compared to standard obstetrical care (control) to determine whether it helps to reduce maternal anemia and other adverse pregnancy outcomes. The BETTER intervention includes one motivational interviewing session and bi-weekly text messages to encourage patients to connect with resources that address their social needs, including housing, food, and transportation. Quantitative data will be used to study participant outcomes, including surveys, and electronic health record data.

NCT ID: NCT06261346 Not yet recruiting - Clinical trials for Fuchs' Endothelial Dystrophy

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the safety and efficacy of brief intraoperative corneal endothelial graft incubation in plasma rich in growth factors (PRGF) for reducing postoperative endothelial cell loss.

NCT ID: NCT06261060 Not yet recruiting - Hematopoietic Clinical Trials

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Start date: August 31, 2024
Phase: Phase 2
Study type: Interventional

To learn about the safety and effects of low-dose sirolimus in participants with RUNX1-FPD.

NCT ID: NCT06261034 Recruiting - Clinical trials for Obstructive Sleep Apnea

A Study of Sex Differences in Neurocirculatory Control

Start date: July 2024
Phase:
Study type: Observational

The purpose of this study is to investigate potential sex differences in neurocirculatory control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

NCT ID: NCT06260956 Not yet recruiting - Clinical trials for Food Allergy in Infants

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

ESCAPE
Start date: September 2024
Phase: N/A
Study type: Interventional

Peanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on maternal consumption or avoidance during pregnancy and breastfeeding.